舌根癌迟发性放射性骨坏死致18F-FDG高摄取一例
本病例报告描述一例舌根癌治疗后患者,18F-FDG PET显示右侧下颌支(SUVmax 17.4)、左侧下颌体(SUVmax 13.6)及左侧胸膜沉积(SUVmax 17.4)异常高摄取,疑似肿瘤复发。胸水穿刺证实转移性疾病,但CT引导下颌病灶活检示坏死组织,确诊放射性骨坏死(ORN)。患者接受姑息化疗,6个月随访期间未见下颌骨复发。
要点
- 舌根癌治疗后下颌骨局灶性FDG高摄取需鉴别放射性骨坏死与肿瘤复发。
- 胸水穿刺证实转移,但下颌骨活检示坏死组织,确诊ORN。
- 6个月随访未见下颌骨复发,提示ORN可表现为极高SUVmax。
核心结论
- 放射性骨坏死可导致下颌骨18F-FDG极高摄取,易误判为肿瘤复发。
研究设计与样本
- 单病例报告,描述一例舌根癌治疗后患者的18F-FDG PET表现及活检确诊过程。
主要发现
- 右侧下颌支SUVmax 17.4,左侧下颌体SUVmax 13.6,左侧胸膜沉积SUVmax 17.4。
- 胸水穿刺吸液显示转移性疾病证据。
- CT引导下颌病灶活检示坏死组织,确诊放射性骨坏死。
- 患者接受姑息化疗,6个月随访期间未见下颌骨复发。
临床怎么用
- 对放疗后下颌骨FDG高摄取灶,应结合活检排除放射性骨坏死,避免误诊复发。
局限性
- 单病例报告,结论外推受限;未报告ORN发生时间、放疗剂量等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Differentiating osteoradionecrosis (ORN) from tumor recurrence is challenging. This report is rare documentation of false-positive F-FDG PET scan attributed to ORN in a patient previously treated for carcinoma of base of tongue (Ca BOT). Extraordinarily high F-FDG uptake was seen in right ramus (SUVmax, 17.4), left body mandible (SUVmax, 13.6) with left pleural deposits (SUVmax, 17.4). Tumor recurrence was suspected. Pleural fluid aspirate showed evidence of metastatic disease. However, CT-guided biopsy of mandibular lesions revealed necrotic tissue. Hence diagnosis of ORN was established. Patient was put on palliative chemotherapy. No mandibular recurrence was noted during 6-month follow-up period.
引用
- Dholam KP, Singh GP, Agarwal JP, et al. 18F FDG Uptake Due to Late-Onset Osteoradionecrosis for Tongue Base Carcinoma. Clin Nucl Med. 2019. PMID: 30789393. doi:10.1097/RLU.0000000000002481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。